Home › NDC Lookup › RxCUI directory › RxCUI 477391

Levofloxacin 25 MG/ML Oral Solution — RxCUI 477391

RxNorm drug concept · Semantic clinical drug
RxCUI 477391 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI477391
Official nameLevofloxacin 25 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevofloxacin 25 MG per 1 ML Oral Solution; levoFLOXacin 25 MG in 1 mL Oral Solution; levofloxacin 250 MG per 10 ML Oral Solution; levofloxacin 500 MG per 20 ML Oral Solution
FDA products mapped2
Package NDCs mapped6
Reported Medicaid activity (SDUD)5,529 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levofloxacin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats serious bacterial infections in adults, such as pneumonia, skin infections, urinary and kidney infections, and prostatitis. It is also used after anthrax exposure and for...
  • What is levofloxacin injection used for?
  • A nurse or clinician gives it as a slow drip into a vein, usually once a day over 60 to 90 minutes. It is never pushed quickly, since that can drop your blood pressure. Drink enoug...
  • Nausea, headache, diarrhea, trouble sleeping, constipation and dizziness are the most common. These are usually manageable, but tell your care team if they bother you.
📖 Read our full Levofloxacin Injection guide →

🕸️ Concept Web — How Levofloxacin 25 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levofloxacin 25 MG/ML Oral Solution RxCUI 477391

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Levofloxacin 82122
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levofloxacin Oral Solution 477392
    • Levofloxacin Oral Liquid Product 1163466
    • Levofloxacin Oral Product 1163467
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Levofloxacin 25 MG/ML 316144

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levofloxacin 25 MG/ML SCDC · 316144
  • Levofloxacin Oral Solution SCDF · 477392
  • Levofloxacin Oral Liquid Product SCDG · 1163466
  • Levofloxacin Oral Product SCDG · 1163467

📦 FDA Products & Package NDCs

2 products · 6 package NDCs
6 package NDCs map to RxCUI 477391 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00527-1948-66 1 BOTTLE, PLASTIC in 1 CARTON (0527-1948-66) / 100 mL in 1... Levofloxacin Lannett Company, Inc. 2018-05-25
00527-1948-68 1 BOTTLE, PLASTIC in 1 CARTON (0527-1948-68) / 200 mL in 1... Levofloxacin Lannett Company, Inc. 2018-05-25
00527-1948-70 1 BOTTLE, PLASTIC in 1 CARTON (0527-1948-70) / 480 mL in 1... Levofloxacin Lannett Company, Inc. 2018-05-25
70954-0852-10 100 mL in 1 BOTTLE (70954-852-10) Levofloxacin ANI Pharmaceuticals, Inc. 2024-03-26
70954-0852-20 200 mL in 1 BOTTLE (70954-852-20) Levofloxacin ANI Pharmaceuticals, Inc. 2024-03-26
70954-0852-30 480 mL in 1 BOTTLE (70954-852-30) Levofloxacin ANI Pharmaceuticals, Inc. 2024-03-26
Observed labelers: ANI Pharmaceuticals, Inc. (3) · Lannett Company, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.9544
Range $1.9119–$1.9969 · middle 50% $1.9119–$1.9969 · 4 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.